Screening of some medicinal plants for their pancreatic lipase inhibitory potential

Jordan Journal of Pharmaceutical Sciences

Volumn 4, Issue 2, 2011, Pages 81-88

  Bustanji, Yasser ^a   Mohammad, Mohammad ^a   Hudaib, Mohammad ^a   Tawaha, Khaled ^a   Al Masri, Ihab M ^b   AlKhatib, Hatim S ^a   Issa, Ala ^a   Alali, Feras Q ^c  

^a UNIVERSITY OF JORDAN   (Jordan)

^b Faculty of Pharmacy   (Philippines)

^c JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

Anti lipase Activity; Hyperlipidaemia; Medicinal Plants; Obesity; Pancreatic Lipase; Plant Extracts

Indexed keywords

ACHILLEA BIEBERSTEINII EXTRACT; ADONIS PALAESTINA EXTRACT; ANAGALLIS ARVENSIS EXTRACT; ANTHEMIS PALAESTINA EXTRACT; CALENDULA ARVENSIS EXTRACT; CLEOME AFRICANA EXTRACT; CONVOLVULUS ALTHEAOIDES EXTRACT; HAPLOPHYLLUM BUXBAUMII EXTRACT; HYPECOUM DIMIDIATUM EXTRACT; LINUM PUBESCENS EXTRACT; ONOSMA GIGANTEUM EXTRACT; PLANT EXTRACT; RESEDA ALBA EXTRACT; RESEDA LUTEA EXTRACT; SALVIA SPINOSA EXTRACT; SILENE AEGYPTIACA EXTRACT; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; VARTHEMIA IPHIONOIDES EXTRACT;

ACHILLEA; ADONIS PALAESTINA; ANAGALLIS ARVENSIS; ANTHEMIS PALAESTINA; ARTICLE; CALENDULA ARVENSIS; CHRYSANTHEMUM CORONARIUM; CLEOME AFRICANA; CONTROLLED STUDY; CONVOLVULUS ALTHEAOIDES; DRUG MECHANISM; DRUG SCREENING; ENZYME INHIBITION; ETHNOPHARMACOLOGY; FAGONIA ARABICA; HAPLOPHYLLUM BUXBAUMII; HYPECOUM DIMIDIATUM; HYPERICUM TRIQUETRIFOLIUM; LINUM PUBESCENS; MALVA NICAEENSIS; MEDICINAL PLANT; NONHUMAN; ONONIS NATRIX; ONOSMA GIGANTEUM; ORIGANUM SYRIACA; PARONYCHIA ARGENTEA; PHYTOCHEMISTRY; RESEDA ALBA; RESEDA LUTEA; SALVIA SPINOSA; SILENE AEGYPTIACA; SPECTROPHOTOMETRY; VARTHEMIA IPHIONOIDES;

EID: 79961084435     PISSN: 19957157     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Cairns E. Obesity: the fat lady sings? Drug Discov. Today 2005; 10:305-307.
2. Vega G. L. Results of expert meetings: obesity and cardiovascular disease. Obesity, the metabolic syndrome, and cardiovascular disease. Am. Heart J. 2001; 142:1108-1116.
3. Gurevich-Panigrahi T., Panigrahi S., Wiechec E., Los M. Obesity: pathophysiology and clinical management. Curr. Med. Chem. 2009; 16:506-521.
4. Arbeeny C. M. Addressing the unmet medical need for safe and effective weight loss therapies. Obes. Res. 2004; 12:1191-1196.
5. Foster-Schubert Karen E., Cummings David E. Emerging therapeutic strategies for obesity. Endocr. Rev. 2006; 27:779-793.
6. Bray G. A., Tartaglia L. A. Medicinal strategies in the treatment of obesity. Nature 2000; 404:672-677.
7. Das S. K., Chakrabarti R. Antiobesity therapy: emerging drugs and targets. Curr. Med. Chem. 2006; 13:1429-1460.
8. Cooke D., Bloom S. The obesity pipeline: current strategies in the development of anti-obesity drugs. Nat. Rev. Drug Discov. 2006; 5:919-931.
9. Ioannides-Demos L. L., Proietto J., Tonkin A. M., McNeil J. J. Safety of drug therapies used for weight loss and treatment of obesity. Drug Saf. 2006; 29:277-302.
10. Jandacek R. J., Woods S. C. Pharmaceutical approaches to the treatment of obesity. Drug Discov. Today 2004; 9:874-880.
11. Verger R. Interfacial activation of lipases: Facts and artifacts. Trends Biotechnol. 1997; 15:32-38.
12. Klein S. Long-term pharmacotherapy for obesity. Obes. Res. 2004; 12 Suppl:163S-166S.
13. Lean M. E. J., Campbell P. Orlistat. J. Drug Eval. 2004; 2:179-218.
14. Hadvary P., Lengsfeld H., Wolfer H. Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin. Biochem. J. 1988; 256:357-361.
15. Hauptman J. B., Jeunet F. S., Hartman D. Initial studies in humans with the novel gastrointestinal lipase inhibitor Ro 18-0647 (tetrahydrolipstatin). Am. J. Clin. Nutr. 1992; 55:309S-313S.
16. Drent M. L., Larsson I., William-Olsson T., Quaade F., Czubayko F., von Bergmann K., Strobel W., Sjostrom L., van der Veen E. A. Orlistat (Ro 18-0647), a lipase inhibitor, in the treatment of human obesity: a multiple dose study. Int. J. Obes. Rela. t Metab. Disord. 1995; 19:221-226.
17. Sjostrom L., Rissanen A., Andersen T., Boldrin M., Golay A., Koppeschaar H. P. F., Krempf M. Randomized placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet 1998; 352:167-173.
18. Gullo V. P., McAlpine J., Lam K. S., Baker D., Petersen F. Drug discovery from natural products. J. Ind. Microbiol. Biotechnol. 2006; 33:523-531.
19. Newman D. J., Cragg G. M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 2007; 70:461-477.
20. Koehn F. E., Carter G. T. The evolving role of natural products in drug discovery. Nat. Rev. Drug Discov. 2005; 4:206-220.
21. Birari R. B., Bhutani K. K. Pancreatic lipase inhibitors from natural sources: Unexplored potential. Drug Discov. Today 2007; 12:879-889.
22. Oran S., Al-Eisawi D. Check list of medicinal plants in Jordan. Dirasat Biol. and Med. Sci. 1998; 25:84-111.
23. Cai Y., Luo Q., Sun M., Corke H. Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer. Life Sci. 2004; 74:2157-2184.
24. Lee Y. P., Chung G. H., Rhee J. S. Purification and characterization of pseudomonas fluorescens SIK W1 lipase expressed in Escherichia coli. Biochim. Biophys. Acta, Lipids Lipid Metab. 1993; 1169:156-164.
25. Taha M. O., Dahabiyeh L. A., Bustanji Y., Zalloum H., Saleh S. Combining ligand-based pharmacophore modeling, quantitative structure-activity relationship analysis and in silico screening for the discovery of new potent hormone sensitive lipase inhibitors. J. Med. Chem. 2008; 51:6478-6494.
26. Sharma N., Sharma Vinay K., Seo S-Y. Screening of some medicinal plants for anti-lipase activity. J. Ethnopharmacol. 2005; 97:453-456.
27. Mohammad M., Aiedeh K. M., AlKhatib H. S., Tawaha K., AlKhalidi B., Al-Masri I. M., Hamed S., Bustanji Y. A. Comparative enzymatic inhibition assay as a surrogate indicator of pharmaceutical and potency equivalence of two orlistat formulations. Jordan J. Pharm. Sci. 2010; 3:69-74.
28. Mukherjee M. Human digestive and metabolic lipases-a brief review. J. Mol. Catal. B: Enzym. 2003; 22:369-376.
29. Tawaha K., Alali F. Q., Gharaibeh M., Mohammad M., El-Elimat T. Antioxidant activity and total phenolic content of selected Jordanian plant species. Food Chem. 2007; 104:1372-1378.
30. Masterova I., Grancai D., Grancaiova Z., Pour M., Ubik K. A new flavonoid: Tinctosid from Anthemis tinctoria L. Pharmazie 2005; 60:956-957.
31. Ninomiya K., Matsuda H., Shimoda H., Nishida N., Kasajima N., Yoshino T., Morikawa T., Yoshikawa M. Carnosic acid, a new class of lipid absorption inhibitor from sage. Bioorg. Med. Chem. Lett. 2004; 14:1943-1946.
32. Duan Z., Guo S., He D., Yan X. CN 2007-10120014, 101361886, 2009.
33. Kang S. M., K. R 2005-91850, 2007036871, 2007.
34. Doi M., Wakamatsu K., Tanaka K., JP 2001-327371, 2003128563, 2003.